1. Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies 
Marcelo C. Pasquini, Jennifer Le-Rademacher, Xiaochun Zhu, Andrew Artz, John DiPersio, Hugo F. Fernandez, Shin Mineishi, Masaru Kamishohara, Jayesh Mehta, Yuki Nakamura, Voravit Ratanatharathorn, Ronald Sobecks, Jeanne Burkart, Christopher Bredeson 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 8, Pages (August 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidences of TRM (A), disease relapse (B), DFS (C), and OS (D) with the different Bu-based myeloablative conditioning regimens before HCT for myeloid malignancies.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions